Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Genentech Gains Modular Engineered Antibodies in $5B Deal

Natural killer cell

A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal

A.I., Imaging Shown to Predict Immunotherapy Success

Computational biology illustration

Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers. . . . → Read More: A.I., Imaging Shown to Predict Immunotherapy Success

M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency

U.S. and Texas flags

M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency. . . . → Read More: M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency

Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Mountain bluebird

Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Trial Testing Cancer Treatment Delivery Compound

Erkki Ruoslahti

A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer. . . . → Read More: Trial Testing Cancer Treatment Delivery Compound

Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Magnolia Neuroscience

A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Cancer Drug Delivery Through Milk Particles Under Study

Cattle

A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions. . . . → Read More: Cancer Drug Delivery Through Milk Particles Under Study

Precision Medicine Technique Devised for Brain Tumors

Brain tumor graphic

A process for quickly determining genetic mutations behind brain tumors and delivering a treatment addressing those mutations is shown to extend the survival of lab mice induced with those tumors. . . . → Read More: Precision Medicine Technique Devised for Brain Tumors

Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

T-cells illustration

Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

Infographic – U.S. Smoking Rate Hits New Low

Chart: smoking in the U.S.

These data show fewer than 1 in 6 Americans, or 16 percent, smoked a cigarette in the past week. . . . → Read More: Infographic – U.S. Smoking Rate Hits New Low